Patents by Inventor Song-Eng Kathryn Cheah

Song-Eng Kathryn Cheah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11759437
    Abstract: The present invention describes a method of preventing, ameliorating and/or treating disorders or diseases associated with the integrated stress response (ISR) involving the p-eIF2? pathway arising from various cellular stresses such as oxidative stress, hypoxia and ER stress, chronic or prolonged bio-mechanical stress. In one embodiment, the present invention provides a method which prevents or alleviates aberrant cell differentiation that is caused by the activation of the integrated stress response and thereby prevents or alleviates conditions, disorders or diseases resulting therefrom. In one embodiment, ISR-associated diseases subject to the present invention include but are not limited to skeletal disorders including disc degeneration, MCDS and other skeletal dysplasias, cancers, inflammatory diseases, diabetes, fibrosis, obesity and neurodegenerative diseases.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: September 19, 2023
    Assignee: The University of Hong Kong
    Inventors: Song Eng Kathryn Cheah, Danny Chan, Cheng Wang, Cheuk Wing Wilson Chan
  • Publication number: 20190240171
    Abstract: The present invention describes a method of preventing, ameliorating and/or treating disorders or diseases associated with the integrated stress response (ISR) involving the p-eIF2? pathway arising from various cellular stresses such as oxidative stress, hypoxia and ER stress, chronic or prolonged bio-mechanical stress. In one embodiment, the present invention provides a method which prevents or alleviates aberrant cell differentiation that is caused by the activation of the integrated stress response and thereby prevents or alleviates conditions, disorders or diseases resulting therefrom. In one embodiment, ISR-associated diseases subject to the present invention include but are not limited to skeletal disorders including disc degeneration, MCDS and other skeletal dysplasias, cancers, inflammatory diseases, diabetes, fibrosis, obesity and neurodegenerative diseases.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 8, 2019
    Inventors: Song Eng Kathryn CHEAH, Danny CHAN, Cheng WANG, Cheuk Wing Wilson CHAN
  • Patent number: 9464271
    Abstract: A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modeling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: October 11, 2016
    Assignee: Versitech Limited
    Inventors: Barbara Pui Chan, Godfrey Chi-Fung Chan, Hoi Ling Wong, Pik To Cheung, Song-Eng Kathryn Cheah, Danny Chan
  • Publication number: 20140170745
    Abstract: A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modeling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 19, 2014
    Applicant: The University of Hong Kong
    Inventors: Barbara Pui Chan, Godfrey Chi-Fung Chan, Hoi Ling Wong, Pik To Cheung, Song-Eng Kathryn Cheah, Danny Chan
  • Patent number: 8679809
    Abstract: A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modeling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: March 25, 2014
    Assignee: The University of Hong Kong
    Inventors: Barbara Pui Chan, Godfrey Chi-Fung Chan, Hoi Ling Wong, Pik To Cheung, Song-Eng Kathryn Cheah, Danny Chan